SN
Sudhakar Namdeorao Bokare
About Sudhakar Namdeorao Bokare
Data last updated:
Sudhakar Namdeorao Bokare is a Director at Padmashri Institute Of Medical Sciences And Research Centre Private Limited (since 2021). The company operates in Healthcare. Padmashri Institute Of Medical Sciences And Research Centre Private Limited reported revenue of ₹42,000 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Jun 2021 | 2021 | ₹42,000 (FY 2025) | Active |
Board colleagues of Sudhakar Namdeorao Bokare
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudhakar Namdeorao Bokare
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudhakar Namdeorao Bokare
Sudhakar Namdeorao Bokare currently holds 1 directorship: Padmashri Institute Of Medical Sciences And Research Centre Private Limited (Director, since 25 Jun 2021, revenue ₹42,000 (FY 2025)).
Sudhakar Namdeorao Bokare was first appointed on 25 Jun 2021 as Director at Padmashri Institute Of Medical Sciences And Research Centre Private Limited.
The current boards of Sudhakar Namdeorao Bokare's companies include Abhishek Satyawan Jadhav (Padmashri Institute Of Medical Sciences And Research Centre Private Limited), Anjali Nilesh More (Padmashri Institute Of Medical Sciences And Research Centre Private Limited), Aruna Babruwahan Kadam (Padmashri Institute Of Medical Sciences And Research Centre Private Limited), Hansraj Dadaraoji Vaidya (Padmashri Institute Of Medical Sciences And Research Centre Private Limited), Sanjeevkumar Ramchandra Kalkekar (Padmashri Institute Of Medical Sciences And Research Centre Private Limited), Sheela Sunil Kadam (Padmashri Institute Of Medical Sciences And Research Centre Private Limited), among others.